Related Experiment Video
Updated: Jul 8, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
Cancer cachexia: pathophysiologic aspects and treatment options.
Erkan Topkan1, Ali Aydin Yavuz, Ozgur Ozyilkan
1Department of Radiation Oncology, Baskent University Medical Faculty, Adana Research and Treatment Centre, 01120, Adana/ Turkey. drerkantopkan@yahoo.com
Asian Pacific Journal of Cancer Prevention : APJCP
|December 28, 2007
Summary
Cancer cachexia causes significant weight loss in terminally ill patients. Current treatments focus on prevention, but new strategies are needed to reverse this life-threatening condition.
Area of Science:
- Oncology
- Metabolic Medicine
- Pathophysiology
Background:
- Cancer cachexia is a severe syndrome causing progressive weight loss and muscle wasting.
- It affects 40-85% of terminally ill cancer patients and contributes to over 20% of cancer deaths.
- Current therapeutic approaches primarily focus on prevention, with limited success in reversing established cachexia.
Purpose of the Study:
- To review current preclinical and clinical knowledge of cancer cachexia.
- To explore the pathophysiology and biochemical changes associated with this condition.
- To discuss existing and potential future therapeutic strategies for cancer cachexia.
Main Methods:
- Literature review of preclinical studies.
- Analysis of clinical trial data.
- Synthesis of current understanding of cancer cachexia pathophysiology.
Main Results:
- Cancer cachexia is a complex syndrome with multifactorial origins.
- Existing treatments are largely ineffective in reversing cachexia.
- Understanding pathophysiology is key to developing novel treatments.
Conclusions:
- Further research into the mechanisms of cancer cachexia is crucial.
- Development of effective treatments requires a deeper understanding of its pathophysiology.
- Novel therapeutic strategies are urgently needed to improve patient outcomes.
Related Concept Videos
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...